-
The variable genomic landscape during osteosarcoma progression: insights from a longitudinal WGS analysis
Study
EGAS50000000329
-
Personalized peptide vaccination among 173 patients with IDH wildtype glioblastoma: a retrospective analysis
Study
EGAS50000000449
-
Identifying New Genetic Subtypes in Follicular Lymphoma
Study
EGAS50000000435
-
Disease recurrence after pathologic response (Recurrence DNAseq)
Study
EGAS50000000488
-
Immune signature of malignant melanoma in pregnancy
Study
EGAS50000000492
-
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard and high risk myeloma
Study
EGAS00001004558
-
BulkRNAseq - Notch Signaling Maintains a Progenitor-Like Subclass of Hepatocellular Carcinoma
Study
EGAS50000000515
-
Large B cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphoma
Study
EGAS50000000564
-
ATACseq - Notch Signaling Maintains a Progenitor-Like Subclass of Hepatocellular Carcinoma
Study
EGAS50000000516
-
scRNAseq - Notch Signaling Maintains a Progenitor-Like Subclass of Hepatocellular Carcinoma
Study
EGAS50000000517
-
Target sequencing for 53 synovial sarcoma patients
Study
EGAS50000000522
-
Single-cell transcriptomics of neuroblastoma tumors
Study
EGAS50000000223
-
Contribution of specific cell types to the development of Barrett’s esophagus and carcinoma via germline genetic risk
Study
EGAS50000000530
-
A Genomics-Driven Artificial Intelligence-Based Model Classifies Breast Invasive Lobular Carcinoma and Discovers CDH1 Inactivating Mechanisms
Study
EGAS50000000485
-
Single cell RNA and ATAC sequencing data from GBM patients
Study
EGAS50000000547
-
Genomic Profile of Multiple Localised Spiradenoma and Spiradenocarcinoma
Study
EGAS50000000554
-
Divergent WNT Signaling and Drug Sensitivity Profiles within Hepatoblastoma Tumors and Organoids
Study
EGAS50000000561
-
Identification and characterization of tertiary lymphoid structures in brain metastases
Study
EGAS50000000563
-
Identification of HER2-positive breast cancer molecular subtypes with potential clinical implications in the ALTTO clinical trial
Study
EGAS50000000525
-
3D genome topology distinguishes molecular subgroups of medulloblastoma
Study
EGAS50000000540
-
Multiple myeloma treated with T-cell redirecting immunotherapies
Study
EGAS50000000546
-
Whole exome sequencing of pre-invasive lung adenocarcinoma in non-smokers
Study
EGAS50000000438
-
Selective Elimination of Immunosuppressive T cells in Patients with Multiple Myeloma
Study
EGAS00001004915
-
Characterization of copy number quiet oral cancer
Study
EGAS50000000558
-
Tumor Evolution Analysis Uncovered Immune-Escape Related Mutations in Relapsed Diffuse Large B-Cell Lymphoma
Study
EGAS50000000032